Evolution of Intestinal Gases and Fecal Short-Chain Fatty Acids Produced in vitro by Preterm Infant Gut Microbiota During the First 4 Weeks of Life

Background: The production of intestinal gases and fecal short-chain fatty acids (SCFAs) by infant gut microbiota may have a significant impact on their health, but information about the composition and volume of intestinal gases and SCFA profiles in preterm infants is scarce.Objective: This study examined the change of the composition and volume of intestinal gases and SCFA profiles produced by preterm infant gut microbiota in vitro during the first 4 weeks of life.Methods: Fecal samples were obtained at five time points (within 3 days, 1 week, 2 weeks, 3 weeks, and 4 weeks) from 19 preterm infants hospitalized in the neonatal intensive care unit (NICU) of Shanghai Children's Hospital, Shanghai Jiao Tong University between May and July 2020. These samples were initially inoculated into four different media containing lactose (LAT), fructooligosaccharide (FOS), 2′-fucosyllactose (FL-2), and galactooligosaccharide (GOS) and thereafter fermented for 24 h under conditions mimicking those of the large intestine at 37.8°C under anaerobic conditions. The volume of total intestinal gases and the concentrations of individual carbon dioxide (CO2), hydrogen (H2), methane (CH4), and hydrogen sulfide (H2S) were measured by a gas analyzer. The concentrations of total SCFAs, individual acetic acid, propanoic acid, butyric acid, isobutyric acid, pentanoic acid, and valeric acid were measured by gas chromatography (GC).Results: The total volume of intestinal gases (ranging from 0.01 to 1.64 ml in medium with LAT; 0–1.42 ml with GOS; 0–0.91 ml with FOS; and 0–0.44 ml with FL-2) and the concentrations of CO2, H2, H2S, and all six fecal SCFAs increased with age (p-trends < 0.05). Among them, CO2 was usually the predominant intestinal gas, and acetic acid was usually the predominant SCFA. When stratified by birth weight (<1,500 and ≥1,500 g), gender, and delivery mode, the concentration of CO2 was more pronounced among infants whose weight was ≥1,500 g than among those whose weight was <1,500 g (p-trends < 0.05).Conclusions: Our findings suggested that the intestinal gases and SCFAs produced by preterm infant gut microbiota in vitro increased with age during the first 4 weeks of life.

Download Full-text

Associations between disordered gut microbiota and changes of neurotransmitters and short-chain fatty acids in depressed mice

Translational Psychiatry ◽

10.1038/s41398-020-01038-3 ◽

2020 ◽

Vol 10 (1) ◽

Cited By ~ 1

Author(s):

Min Wu ◽

Tian Tian ◽

Qiang Mao ◽

Tao Zou ◽

Chan-juan Zhou ◽

...

Keyword(s):

Fatty Acids ◽

Acetic Acid ◽

Gut Microbiota ◽

Molecular Mechanisms ◽

Short Chain Fatty Acids ◽

Short Chain ◽

Rrna Gene ◽

Microbial Composition ◽

Fecal Samples ◽

Chain Fatty Acids

Abstract Mounting evidence suggests that gut microbiota can play an important role in pathophysiology of depression, but its specific molecular mechanisms are still unclear. This study was conducted to explore the associations between changes in neurotransmitters and short-chain fatty acids (SCFAs) and altered gut microbiota in depressed mice. Here, the chronic restraint stress (CRS) model of depression was built. The classical behavioral tests were conducted to assess the depressive-like behaviors of mice. The 16S rRNA gene sequence extracted from fecal samples was used to assess the gut microbial composition. Liquid and gas chromatography mass spectroscopy were used to identify neurotransmitters in hypothalamus and SCFAs in fecal samples, respectively. Finally, 29 differential bacteria taxa between depressed mice and control mice were identified, and the most differentially abundant bacteria taxa were genus Allobaculum and family Ruminococcaceae between the two groups. The acetic acid, propionic acid, pentanoic acid, norepinephrine, 5-HIAA and 5-HT were significantly decreased in depressed mice compared to control mice. Genus Allobaculum was found to be significantly positively correlated with acetic acid and 5-HT. Taken together, these results provided novel microbial and metabolic frameworks for understanding the role of microbiota-gut-brain axis in depression, and suggested new insights to pave the way for novel therapeutic methods.

Download Full-text

Effect of resistant starch structure on short-chain fatty acids production by human gut microbiota fermentation in vitro

Starch - Stärke ◽

10.1002/star.201200166 ◽

2013 ◽

Vol 65 (5-6) ◽

pp. 509-516 ◽

Cited By ~ 22

Author(s):

Zhongkai Zhou ◽

Xiaohong Cao ◽

Julia Y. H. Zhou

Keyword(s):

Fatty Acids ◽

Gut Microbiota ◽

Resistant Starch ◽

Short Chain Fatty Acids ◽

Short Chain ◽

Human Gut ◽

Human Gut Microbiota ◽

Starch Structure ◽

Chain Fatty Acids

Download Full-text

A unique polysaccharide from Hericium erinaceus mycelium ameliorates acetic acid-induced ulcerative colitis rats by modulating the composition of the gut microbiota, short chain fatty acids levels and GPR41/43 respectors

International Immunopharmacology ◽

10.1016/j.intimp.2019.02.038 ◽

2019 ◽

Vol 71 ◽

pp. 411-422 ◽

Cited By ~ 12

Author(s):

Shuai Shao ◽

Dandan Wang ◽

Wei Zheng ◽

Xiangyan Li ◽

He Zhang ◽

...

Keyword(s):

Ulcerative Colitis ◽

Fatty Acids ◽

Acetic Acid ◽

Gut Microbiota ◽

Short Chain Fatty Acids ◽

Short Chain ◽

Hericium Erinaceus ◽

Chain Fatty Acids

Download Full-text

Dietary and anthropometric factors affecting the potential of gut microbiota to utilize dietary fiber and produce short-chain fatty acids

Proceedings of The Nutrition Society ◽

10.1017/s0029665120002013 ◽

2020 ◽

Vol 79 (OCE2) ◽

Author(s):

Anna M. Malinowska ◽

Marcin Schmidt ◽

Malgorzata Majcher ◽

Hanna Przydatek ◽

Marta Szaban ◽

...

Keyword(s):

Fatty Acids ◽

Acetic Acid ◽

Gut Microbiota ◽

Dietary Fiber ◽

Propionic Acid ◽

Butyric Acid ◽

Dietary Pattern ◽

Short Chain Fatty Acids ◽

Short Chain ◽

Chain Fatty Acids

AbstractSome species of gut bacteria produce short-chain fatty acids (SCFAs) from dietary fiber—mainly acetate, propionate, and butyrate. The composition of human gut microbiota is dependent on dietary intake and health status. The aim of this study was to assess the effect of diet and anthropometric parameters on the potential of gut microbiota to metabolize dietary fiber and produce SCFA.A group of 200 men and women aged 31 to 50 years old participated in the study. The diet was assessed using three-day dietary records and the dietary pattern was determined using score methods. The potential to utilize water-insoluble fiber was assessed by measuring the β-glucosidase enzymatic activity of dissolved feces. To estimate the potential to metabolize water-soluble dietary fiber, cultures containing feces and pectin were incubated under anaerobic conditions for 24 hours. The amounts of fiber, acetic acid, propionic acid, and butyric acid before and after incubation were measured.Pectin utilization correlated positively with the amount of energy intake from fat (r = 0.19) and with the intake of nuts and seeds (r = 0.17) and was negatively correlated with the amount of energy from complex carbohydrates (r = -0.16) and its sources, such as refined grain products (r = -0.15). The dietary pattern did not affect the potential of the gut microbiota to metabolize pectin, but did influence the potential to digest insoluble dietary fiber, as the subjects following the western dietary pattern had lower potential than those following the rational pattern. β-glucosidase activity correlated positively with the intake of dietary fiber (r = 0.19) and intake of its sources, such as fruits (r = 0.18), vegetables (r = 0.21), and nuts and seeds (r = 0.18); it correlated negatively with nonalcoholic beverage intake (r = -0.15) and sugar and honey intake (r = -0.16). The potential to synthesize acetic acid correlated negatively with dietary indices and dietary fiber intake (r = -0.18). The potential to synthesize propionic acid correlated negatively with hip and waist circumference (r = -0.14, -0.15, respectively). The potentials to synthesize both propionic and butyric acid were affected by the intake of nuts and seeds (r = 0.18, 0.21, respectively).Diet affects the potential of gut microbiota to utilize dietary fiber and to produce SCFAs. The impact of anthropometry parameters was only seen on the potential to synthesize propionic acid.

Download Full-text

Effect of nutritionally complete formula on gut microbiota and their metabolite in fecal batch fermentation system

Functional Foods in Health and Disease ◽

10.31989/ffhd.v11i12.841 ◽

2021 ◽

Vol 11 (12) ◽

pp. 641

Author(s):

Santad Wichienchot ◽

Kridsada Keawyok

Keyword(s):

Fatty Acids ◽

Lactic Acid ◽

Gut Microbiota ◽

High Performance ◽

Lactic Acid Production ◽

Short Chain Fatty Acids ◽

Uremic Toxins ◽

Short Chain ◽

Chain Fatty Acids

Background: Emerging evidence has revealed that the gut microbiota is significantly altered, contributing to the occurrence and development of chronic kidney disease (CKD). Therefore, the target of increasing short-chain fatty acids (SCFAs) and lactic acid production and reduction of uremic toxins were interested. Objective: To study the effect of the nutritionally complete formula (Synplus) developed for hemodialysis patients on gut microbiota and their metabolite in in vitro fecal fermentation of healthy volunteers.Methods: Fecal fermentation (in vitro) using batch culture in an environment mimicking human large intestine was used to study the change of gut microbiota by next generation sequencing (NGS) during fermentation of the developed formula (Synplus), commercial formula (Nepro®) and control. The gut metabolites were determined including short-chain fatty acids (acetic, propionic, and butyric) and lactic acid. The uremic toxins (p-cresol and indole) were determined by high performance liquid chromatography (HPLC).Results: The increase of Lactobacillus spp. (53.74%) and Bifidobacterium spp. (29.35%) was observed in the developed product (Synplus) compared with control at 48 hrs fermentation meanwhile, these genera were decreased in a commercial product (Nepro®). Moreover, the abundance of the genus Escherichia spp. (12.33%) was observed in Nepro® fermentation, with Escherichia albertii species which is a newly discovered pathogen of the gastrointestinal tract. Microbial metabolites produced by fecal fermentation of Synplus revealed that propionate, acetate, and butyrate increased significantly (p<0.05). All the samples evaluated exhibited acetate in abundance when compared to other SCFAs. Acetate was the most abundant SCFA in all samples. The concentrations of acetate for Synplus fermentation were 15.63±3.26, 147.29±2.39, 162.28±4.13 and 189.39±0.17 mM at 0, 12, 24, and 48 hrs respectively. Total SCFAs produced from Synplus was significantly increased (p<0.05) and higher than control and Nepro®, respectively. The concentration of p-cresol at 48 hrs fermentation for control, Synplus and Nepro® were 3.79±0.12, 6.31±2.37 and 11.59±0.10 µg/mL, respectively. The indole concentration of control, Synplus and Nepro® were 3.64±0.08, 15.06±3.56 and 12.81±1.68 µg/mL, respectively. There were also indicated that imbalance of gut microbiota was related with the ratio of uremic toxins (indole and p-cresol) to SCFAs.CONCLUSION: The synbiotic product containing prebiotic and probiotic may be used to improve gut microbiota thus reducing the risk of kidney disease.Keywords: synbiotic, gut microbiota, uremic toxins, SCFA, CKD

Download Full-text

Lung Immune Tone via Gut-Lung Axis: Gut-derived LPS and Short-chain Fatty Acids' immunometabolic regulation of Lung IL-1β, FFAR2 and FFAR3 Expression

AJP Lung Cellular and Molecular Physiology ◽

10.1152/ajplung.00421.2020 ◽

2021 ◽

Author(s):

Qing Liu ◽

Xiaoli Tian ◽

Daisuke Maruyama ◽

Mehrdad Arjomandi ◽

Arun Prakash

Keyword(s):

Fatty Acids ◽

Gut Microbiota ◽

Lung Tissue ◽

Gut Microbiome ◽

Human Lung ◽

Short Chain Fatty Acids ◽

Short Chain ◽

Human Lung Tissue ◽

Chain Fatty Acids

Microbial metabolites produced by the gut microbiome, e.g. short-chain fatty acids (SCFA), have been found to influence lung physiology and injury responses. However, how lung immune activity is regulated by SCFA is unknown. We examined fresh human lung tissue and observed the presence of SCFA with inter-individual variability. In vitro, SCFA were capable of modifying the metabolic programming in LPS-exposed alveolar macrophages (AM). We hypothesized that lung immune tone could be defined by baseline detection of lung intracellular IL-1β. Therefore, we interrogated naïve mouse lungs with intact gut microbiota for IL-1β mRNA expression and localized its presence within alveolar spaces, specifically within AM subsets. We established that metabolically active gut microbiota, that produce SCFA, can transmit LPS and SCFA to the lung and thereby could create primed lung immunometabolic tone. To understand how murine lung cells sensed and upregulated IL-1β in response to gut microbiome-derived factors, we determined that, in vitro, AM and AT2 cells expressed SCFA receptors, FFAR2, FFAR3, and IL-1β but with distinct expression patterns and different responses to LPS. Finally, we observed that IL-1β, FFAR2 and FFAR3 were expressed in isolated human AM and AT2 cells ex-vivo, but in fresh human lung sections in situ, only AM expressed IL-1β at rest and after LPS challenge. Together, this translational study using mouse and human lung tissue and cells point to an important role for the gut microbiome and their SCFA in establishing and regulating lung immune tone.

Download Full-text

Short-Chain Fatty Acids Prevent Diabetic Nephropathy In Vivo and In Vitro

Diabetes ◽

10.2337/db18-92-or ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 92-OR ◽

Cited By ~ 1

Author(s):

WEI HUANG ◽

YONG XU ◽

YOUHUA XU ◽

LUPING ZHOU ◽

CHENLIN GAO

Keyword(s):

Fatty Acids ◽

Diabetic Nephropathy ◽

Short Chain Fatty Acids ◽

Short Chain ◽

Chain Fatty Acids

Download Full-text

Faculty Opinions recommendation of Gut microbiota-derived short-chain Fatty acids, T cells, and inflammation.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725300895.793509795 ◽

2015 ◽

Author(s):

Jonathan Kaunitz

Keyword(s):

Fatty Acids ◽

T Cells ◽

Gut Microbiota ◽

Short Chain Fatty Acids ◽

Short Chain ◽

Chain Fatty Acids

Download Full-text

The Consumption of Galactomannan Effervescent Drinks made from Coconut Pulp Waste and Colonic Microbiota in Wistar Rats

International Journal of Probiotics and Prebiotics ◽

10.37290/ijpp2641-7197.15:52-56 ◽

2020 ◽

Vol 15 (1) ◽

pp. 52-56

Author(s):

Sri Winarti ◽

Agung Pasetyo

Keyword(s):

Fatty Acids ◽

Gut Microbiota ◽

Wistar Rats ◽

Short Chain Fatty Acids ◽

Short Chain ◽

E Coli ◽

Colonic Microbiota ◽

Male Wistar Rats ◽

Lactobacillus Spp ◽

Chain Fatty Acids

The consumption of prebiotics is known to affect the balance of gut microbiota. The purpose of this study was to explore how a galactomannan-rich effervescent drink can affect the population of Lactobacillus, Bifidobacterium, E. coli, and the concentration of short-chain fatty acids in the cecum of rats. Twenty-eight male Wistar rats (aged 2 months) were divided equally into 7 groups and treated orally each day for 15 days with 2 mL effervescent drinks with increasing levels of prebiotic galactomannan. The dosage of 500 mg galactomannan increased the growth of Lactobacillus spp. and Bifidobacterium spp. with inhibition of the growth of E.coli with increased formation of short-chain fatty acids such as acetate, propionate, and butyrate in the cecum of rats.

Download Full-text